Introduction
Reactome is open-source, open access, manually curated and peer-reviewed pathway database. Pathway annotations are authored by expert biologists, in collaboration with Reactome editorial staff and crossreferenced to many bioinformatics databases. A system of evidence tracking ensures that all assertions are backed up by the primary literature. Reactome is used by clinicians, geneticists, genomics researchers, and molecular biologists to interpret the results of high-throughput experimental studies, by bioinformaticians seeking to develop novel algorithms for mining knowledge from genomic studies, and by systems biologists building predictive models of normal and disease variant pathways.
The development of Reactome is supported by grants from the US National Institutes of Health (P41 HG003751), University of Toronto (CFREF Medicine by Design), European Union (EU STRP, EMI-CD), and the European Molecular Biology Laboratory (EBI Industry program).
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Metabolism of ingested SeMet, Sec, MeSec into H2Se ↗ Location: Selenoamino acid metabolism
Stable identifier: R-HSA-2408508
Inorganic (selenite, SeO3(2-); and selenate, SeO4(2-)) and organic (selenocysteine, Sec; and selenomethionine, SeMet) forms of selenium can introduced in the diet where they are transformed into the intermediate selenide (Se(2-)) through the trans-selenation pathway, selenocysteine lyase (SCLY), and cystathionine gamma-lyase (CTH).
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Metabolism of ingested MeSeO2H into MeSeH ↗ Location: Selenoamino acid metabolism
Stable identifier: R-HSA-5263617
Methylseleninic acid (MeSeO2H) is reduced to methylselenenic acid (MeSeOH) and then further reduced to methylselenol (MeSeH) by thioredoxin reductase (TXNRD1). Lu, J., Berndt, C., Holmgren, A. (2009 
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